Trials / Completed
CompletedNCT01874678
A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- TTY Biopharm · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
Objectives: 1. Primary Objective: To bridge the data of efficacy in term of overall response rate of TS-1 plus cisplatin in Taiwanese advanced NSCLC patients from that gained from Japanese population 2. Secondary Objectives: A. To assess progression free survival B. To assess overall survival C. To bridge the safety profile by assessing the toxicities and tolerability
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-1/Cisplatin |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2013-06-11
- Last updated
- 2016-01-12
Locations
5 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01874678. Inclusion in this directory is not an endorsement.